Treating acute coughs

Mar 24, 2011
Treating acute coughs

(PhysOrg.com) -- Prescribing antibiotics for patients with discoloured phlegm caused by acute cough has little or no effect on alleviating symptoms and recovery, a new University study has found.

Acute cough is one of the common reasons why people visit their GP and accounts for a large proportion of prescribed in the community.

One of the most common questions asked by GPs to their patients is about their phlegm - "Are you coughing anything up?" or "What color is your phlegm?"

Clinicians and patients commonly believe that yellow and green phlegm production is associated with a , which is more likely to benefit from antibiotic treatment compared to non-productive cough or cough that produces clear phlegm.

However, in a new study published in the European Respiratory Journal, Professor Chris Butler and his team from the School of Medicine, together with colleagues from 14 European centers, present data from an observational study of 3402 adult patients with acute cough presenting for health care in 14 primary care networks.

The research found that patients producing discoloured phlegm are prescribed antibiotics more frequently than those not producing phlegm unlike those producing clear/white phlegm.

Crucially, antibiotic treatment was not associated with greater rate or magnitude of symptoms score resolution among those who produced yellow or green phlegm. Neither was recovery among those feeling generally unwell on its own, or taken together with phlegm production, associated with antibiotic treatment.

Clinicians and patients are therefore likely to both be over interpreting the importance of the colour of phlegm in the decision whether or not to prescribe, or take, antibiotics.

Professor Butler, School of Medicine, who led the study, said: "One of the exciting things about this research is that our findings from this large, multi-country observational study resonate with findings from randomized trials where benefit from antibiotic treatment in those producing discolored phlegm has been found to be marginal at best or non-existent.

"Our findings add weight to the message that acute cough in otherwise well adults is a self-limiting condition and does not speed recovery to any meaningful extent.

"In fact, antibiotic prescribing in this situation simply unnecessarily exposes people to side effects from antibiotics, undermines future self care, and drives up antibiotic resistance."

Explore further: FDA OKs Cubist antibiotic for serious infections

More information: The study Antibiotic prescribing for discoloured sputum in acute cough/LRTI was published in the European Respiratory Journal. The paper is available at: erj.ersjournals.com/content/ea… 36.00133910.abstract

add to favorites email to friend print save as pdf

Related Stories

COPD patients often given wrong treatment

Apr 21, 2009

(PhysOrg.com) -- Generally speaking, patients with COPD (Chronic Obstructive Pulmonary Disease) deteriorate suddenly, in bursts, often as a result of bacterial or viral infections.

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.